tert-Butyl hexahydro-1H-pyrrolo[3,4-c]pyridine-2(3H)-carboxylate

Catalog No. :
ACAPCD857
CAS No. :
885270-57-5
Molecular Formula :
C12H22N2O2
Molecular Weight :
226.32

IUPAC Name:tert-butyl octahydro-2H-pyrrolo[3,4-c]pyridine-2-carboxylate

tert-Butyl hexahydro-1H-pyrrolo[3,4-c]pyridine-2(3H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$84.00Login to see priceIn stockInquiry
100mg97%$130.00Login to see priceIn stockIn stock
250mg97%$221.00Login to see priceIn stockIn stock
1g97%$595.00Login to see priceIn stockIn stock
5g97%$2084.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl hexahydro-1H-pyrrolo[3,4-c]pyridine-2(3H)-carboxylate
IUPAC Nametert-butyl octahydro-2H-pyrrolo[3,4-c]pyridine-2-carboxylate
MDL No.MFCD08234697
Molecular FormulaC12H22N2O2
Molecular Weight226.32
SMILESCC(C)(C)OC(=O)N1CC2CCNCC2C1
InChI KeyCQJSNQCNXVJXDM-UHFFFAOYSA-N
Synonym885270-57-5 | TERT-BUTYL HEXAHYDRO-1H-PYRROLO[3,4-C]PYRIDINE-2(3H)-CARBOXYLATE | 236406-56-7 | tert-butyl octahydro-1H-pyrrolo[3,4-c]pyridine-2-carboxylate | OCTAHYDRO-PYRROLO[3,4-C]PYRIDINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER | tert-butyl 1,3,3a,4,5,6,7,7a-octahydr
CAS No.885270-57-5
PubChem CID23282882

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H317
Precautionary Statement(s)
P280

Synthetic Route by SureRoute

1. ACAPCD857 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAPCD857 route product structure diagram
    ACAPCD857885270-57-5 In Stock
Inquiry

2. ACAPCD857 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAPCD857 route product structure diagram
    ACAPCD857885270-57-5 In Stock
Inquiry

Comments (0)